Loading company…
Therapixel SA develops AI software for medical imaging, including MammoScreen for breast cancer detection on mammograms.
Founded in 2013 in Nice, France, Therapixel SA sells MammoScreen, AI software that helps radiologists analyze mammograms, and it is used in more than 150 locations, including Mayo Clinic, through a collaboration with Onsite Women's Health. The company raised EUR 14.3 million in a Series B round as of May 2022 from investors including Crédit Mutuel Equity and Cap Horn. Matthieu Leclerc-Chalvet is CEO, and 2022 revenue was EUR 391,060.50.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in